ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2309건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 34 | Terminated | Usefulness of DORNASE in COVID-19 on HFNO | COVID-19 Pneumonia | Drug: Dornase Alfa Drug: Saline |
Phase 4 | University Medical Centre Ljubljana | OTHER | 10 | All | 18 Years ~ 100 Years | University Medical Centre Ljubljana, Ljubljana, Slovenia |
| 33 | Completed | Using BCG to Protect Senior Citizens During the COVID-19 Pandemic | Vaccine Preventable Disease | Biological: BCG-Denmark Biological: Saline |
Phase 3 | Bandim Health Project, Odense Patient Data Explorative Network, Odense University Hospital, Municipality of Odense | OTHER | 1700 | All | 65 Years ~ 110 Years | Seniorhuset, Odense, Denmark |
| 32 | Unknown status | Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19 | COVID-19 | Drug: prophylactic lactoferrin daily | Phase 3 | Cairo University | OTHER | 200 | All | 18 Years ~ 65 Years | |
| 31 | Unknown status | Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19 | COVID-19 | Drug: Lactoferrin | Phase 3 | Cairo University | OTHER | 150 | All | 18 Years ~ 65 Years | |
| 30 | Unknown status | Utilizing the Crosstalk Among Aerosolized Phenformin , Methylene Blue, Photodynamic Therapy , Zinc and Potassium for Treating Severe COVID-19 Infection and Its Inflammatory Complication | COVID-19 | Combination Product: Combination therapy plus Standard therapy Radiation: Photodynamic therapy Drug: Standard therapy |
Phase 2 | Amr kamel khalil Ahmed, Faculty of Medicine , Kafrelshiekh University, Egypt. | OTHER_GOV | 2 | All | 18 Years ~ 70 Years | Ministry of health.First health cluster ,Riaydh, Riyadh, Saudi Arabia |
| 29 | Terminated | VA CoronavirUs Research and Efficacy Studies-1 | COVID-19 | Drug: Convalescent Plasma Other: Masked Saline Placebo |
Phase 3 | VA Office of Research and Development | FED | 75 | All | 18 Years | Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama, United States Phoenix VA Health Care System, Phoenix, AZ, Phoenix, Arizona, United States Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora, Colorado, United States North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida, United States Orlando VA Medical Center, Orlando, FL, Orlando, Florida, United States James A. Haley Veterans' Hospital, Tampa, FL, Tampa, Florida, United States Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur, Georgia, United States Edward Hines Jr. VA Hospital, Hines, IL, Hines, Illinois, United States VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan, United States John D. Dingell VA Medical Center, Detroit, MI, Detroit, Michigan, United States VA Southern Nevada Healthcare System, North Las Vegas, NV, North Las Vegas, Nevada, United States James J. Peters VA Medical Center, Bronx, NY, Bronx, New York, United States Durham VA Medical Center, Durham, NC, Durham, North Carolina, United States Louis Stokes VA Medical Center, Cleveland, OH, Cleveland, Ohio, United States Oklahoma City VA Medical Center, Oklahoma City, OK, Oklahoma City, Oklahoma, United States VA Portland Health Care System, Portland, OR, Portland, Oregon, United States Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, South Carolina, United States VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas, United States Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States South Texas Health Care System, San Antonio, TX, San Antonio, Texas, United States VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, United States Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond, Virginia, United States William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison, Wisconsin, United States VA Caribbean Healthcare System, San Juan, PR, San Juan, Puerto Rico |
| 28 | Suspended | VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL) | COVID-19 | Drug: Hydroxychloroquine Drug: Azithromycin Drug: Placebo oral tablet |
Phase 3 | Salomeh Keyhani MD, San Francisco VA Health Care System | FED | 300 | All | 216 Months | San Francisco VA, San Francisco, California, United States |
